Sign In
Buy GDRX
$2.57
-0.0900 (-3.38%)
At Close: Jun 22, 2026
These 3 Stocks Are Absurdly Overvalued Right Now
06:10am, Friday, 09'th Apr 2021
The best buy on this list trades over a ridiculous 60 times its future earnings.
GoodRx: Understanding This Misunderstood Disruptor
04:09am, Thursday, 08'th Apr 2021
GoodRx is a free-to-use platform that sources discounts on prescription drugs for patients in the US. The business is growing its user base, which is powering expansion into telehealth and subscriptio
These 5 Hot IPOs Post Weak Q4 Results
10:07pm, Thursday, 01'st Apr 2021
After a handful of companies had their initial public offering (IPO), let's take a deeper look at each of their first quarterly reports. The post These 5 Hot IPOs Post Weak Q4 Results appeared first o
Can GoodRx Bounce Back From Its Pandemic Slowdown?
07:28am, Sunday, 28'th Mar 2021
Some of the drug discounter's growth is out of the company's hands.
GoodRx: A Doctor's Prescription For Your Growth Portfolio
11:51am, Monday, 22'nd Mar 2021
GoodRx: A Doctor's Prescription For Your Growth Portfolio
Could GoodRx Be a Millionaire-Maker Stock?
07:55am, Saturday, 20'th Mar 2021
This healthcare tech company has helped consumers save a cumulative $25 billion on prescription drugs. But that doesn't necessarily make its stock a buy.
Despite More Stock Market Records, These 3 IPO Stocks Got Crushed Friday
05:49pm, Friday, 12'th Mar 2021
Investors aren't seeing the results that they'd hoped for from these newcomers to the public markets.
Why GoodRx Holdings Stock Got Crushed Today
11:14am, Friday, 12'th Mar 2021
Revenue was ahead of expectations, but investors can't shake this massive net loss.
GoodRx co-CEO Doug Hirsch on Biden's vaccine goals and and fourth-quarter results
10:52am, Friday, 12'th Mar 2021
Shares of GoodRx fell after the company released its fourth-quarter results. GoodRx saw its monthly active customers grow by more than 30% year-over-year but missed its EPS estimates.
GoodRx Q4 Update: Solid Growth, Weak Guidance
06:00am, Friday, 12'th Mar 2021
Prescription transaction volume fueled strong revenue growth for the healthcare company in Q4.
GoodRx Holdings' (GDRX) Management on Q4 2020 Results - Earnings Call Transcript
12:40am, Friday, 12'th Mar 2021
GoodRx Holdings' (GDRX) Management on Q4 2020 Results - Earnings Call Transcript
GoodRx stock dips after lower-than-expected quarterly guidance
04:51pm, Thursday, 11'th Mar 2021
Shares of GoodRx Holdings Inc. fell more than 3% in the extended session Thursday after the health-care company reported adjusted earnings that were above Wall Street expectations but guided for lower
GoodRx Releases Fourth Quarter and Full Year 2020 Financial Results
04:07pm, Thursday, 11'th Mar 2021
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings Inc. (Nasdaq: GDRX), America's leading resource for healthcare savings, has released its fourth quarter and full year 2020 financial results and
2 New Healthcare SPACs Worth Adding to Your Watch List
06:20am, Thursday, 04'th Mar 2021
SPAC-mania is in full swing, and the healthcare sector is starting to pop with new offerings.
A Look at GoodRx, Inari, and Amwell
03:25pm, Saturday, 20'th Feb 2021
How have these big healthcare IPOs been doing?
